Innoviz is a small-cap company with minimal sell-side coverage, so no reliable multi-analyst consensus exists. The $0.40 level is drawn from the most recent published price objective rather than a calculated average: Goldman Sachs analyst Mark Delaney lowered the firm's target to $0.40 from $0.50 in the fall of 2026 while keeping a Neutral rating. That figure is also widely carried as the stock's one-year target estimate on major financial data platforms. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For context, the only other identifiable recent target is far higher — Amerx initiated coverage with a Buy and a target near $2.77 in May 2026. That six-month-old figure predates a steep decline and the company's financing activity, so it is treated as stale context rather than a current input. The resulting range of roughly $0.40 to $2.77 underscores how little agreement exists among the handful of analysts who have covered the name.
Shares of INVZ last traded around $0.23, giving the company a market capitalization near $69 million. Reaching $0.40 would require a move of about 76%, which is a very large move for any stock and especially demanding for a pre-profit company that has steadily de-rated. The 52-week range spans roughly $0.21 to $2.03, meaning the current price sits just above its low.
The path would likely require visible progress on both the automotive and defense fronts: sustained revenue growth toward the reaffirmed $67 million–$73 million fiscal 2026 outlook, confirmation that defense orders are scaling, and a signal that cash burn is narrowing. In the most recent quarter, revenue reached a record $18.1 million with a positive gross margin, but adjusted EPS remained negative.
The $0.21 area, near the 52-week low, is the critical support level to watch; a decisive break below it would leave the stock in uncharted territory. On the upside, $0.40 functions as both a round-number psychological level and a widely cited analyst objective, while the $0.50 level — where the target stood before being cut — is the next notable reference point.
Analyst targets generally reflect a roughly 12-month research horizon, though the thin coverage here means any single figure should carry less weight than it would for a heavily covered large-cap. Key items ahead include the third-quarter earnings report, guidance updates and any analyst revisions, defense order announcements, the status of the potential reverse split, and any additional capital-raising activity that would affect dilution. From what I see, monitoring these closely is essential given the volatility.
The $0.40 objective is best understood as the most recent single-analyst benchmark rather than a consensus forecast, given how little coverage Innoviz receives. Reaching it would demand roughly a 76% advance from current levels — a very large move for a company still generating losses and funding itself through dilutive raises. Record revenue, a credible defense expansion, and reaffirmed guidance provide a plausible foundation for recovery, but cash burn, dilution, and the potential reverse split remain substantial obstacles. Investors should weigh the wide dispersion in published targets and watch the next earnings report and any capital-structure decisions closely.
In my analysis of names like INVZ, I often turn to Tickeron's AI Daily Buy/Sell Signals to help track shifting trends in volatile stocks. These tools apply artificial intelligence to scan thousands of securities and flag potential Buy, Sell, or Hold opportunities based on technical patterns and market data. For a low-priced, high-volatility stock such as this one, they offer an efficient way to stay on top of developments without relying solely on manual review. This approach has been useful for me when evaluating whether momentum is building toward levels like the $0.40 target or if risks are mounting.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
The RSI Oscillator for INVZ moved into overbought territory on November 02, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where INVZ advanced for three days, in 189 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
INVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INVZ as a result. In 67 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for INVZ turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 37 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 10-day moving average for INVZ crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INVZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for INVZ entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.388) is normal, around the industry mean (0.753). P/E Ratio (-0.597) is within average values for comparable stocks, (40.047). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.494). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (1.236) is also within normal values, averaging (49.456).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. INVZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AutoPartsOEM